明星大侦探

Dacoit, Rowdy Janardhan Teasers to Launch on a Special Date_我的网站

一 |     December 18, 2025, is shaping up to be an exciting date for Telugu cinema lovers. Two major film teasers are set to be released on the same day. Fans can look forward to first looks from films led by Vijay Deverakonda and Adivi Sesh, making the day extra special.          Teasers of Dacoit and Rowdy Janardhan     After the setback of Kingdom, Vijay Deverakonda is currently shooting for two projects, and Rowdy Janardhan is one of them. It is being directed by Ravi Kiran Kola, who earlier made Raja Vaaru Rani Gaaru. According to latest the buzz the teaser and official title will be unveiled at a grand event in Hyderabad. At the same time, the teaser of Adivi Sesh’s much-awaited action-drama Dacoit, will also be released on the same day. The film has been in production for almost two years. A separate event has been planned for its teaser launch in Mumbai and Hyderabad respectively. Dacoit, an action drama, follows an angry convict seeking vengeance against his former girlfriend who betrayed him. Earlier this year, in May, the filmmakers unveiled one minute teaser. The film revolves around betrayal and revenge.          Both films significant for lead actors     Dacoit is scheduled to release in theatres on March 19, 2025. Mrunal Thakur plays the female lead, while filmmaker Anurag Kashyap makes his Telugu debut in a powerful negative role. The film is directed by Shaneil Deo and mounted on a grand scale. Both films are significant for Sesh and Vijay. Rowdy Janardhan could be a turning point for Vijay Deverakonda, while Dacoit has the potential to take Adivi Sesh’s career to a new level. The special aspect is that both these films are being directed by newcomers, and all eyes are now on December 18, 2025, to see what they have lined up with these films.Also Read: Adivi Sesh and Mrunal Thakur’s Dacoit: Ek Prem Katha to Hit Theatres on Gudi Padwa and Eid Weekend。    获悉，上海市人民政府办公厅印发《上海市战略性新兴产业发展“十五五”规划》。其中提到，加快具有重大知识产权价值的创新药培育开发，建立创新药发现遴选机制，加强AI模型对临床成功率等的辅助预判，推动高质量医疗和临床研究队列数据支撑创新药开发转化。重点发展：1.高临床价值创新药。推动AI技术在靶点挖掘、分子生成、药效模拟等环节赋能应用，支持多功能抗体、通用型细胞、蛋白靶向降解等新机制药物研究转化。2.智能化高端医疗器械。

二 | 支持小型化质子放疗设备、柔性手术机器人等智能化高端医疗器械开发和关键器件材料攻关。3.高端医药研发和医疗服务。支持医药合同研发机构（CRO）搭建AI辅助药物开发模型和自动化实验室，推动合同生产机构（CDMO）加快连续流等先进工艺应用。

三 | 提升国际医疗商保结算、就医流程的便利性。原文链接。

Current article:http://bkk48h.cuiguagonggengaotianwan.shop/ek4l4ky/20260826/1402.html

Published on:21:51:30